Enterprise Value Chart

Historical Enterprise Value Data

View and export this data back to 2014. Start Trial.
Date Value
October 21, 2026 1.315B
October 20, 2026 1.317B
October 19, 2026 1.281B
October 16, 2026 1.252B
October 15, 2026 1.303B
October 14, 2026 1.196B
October 13, 2026 1.217B
October 12, 2026 1.256B
October 09, 2026 1.308B
October 08, 2026 1.305B
October 07, 2026 1.346B
October 06, 2026 1.341B
October 05, 2026 1.323B
October 02, 2026 1.368B
October 01, 2026 1.362B
September 30, 2026 1.417B
September 29, 2026 1.441B
September 28, 2026 2.454B
September 25, 2026 2.393B
September 24, 2026 2.399B
September 23, 2026 2.707B
September 22, 2026 2.881B
September 21, 2026 2.814B
September 18, 2026 2.793B
September 17, 2026 2.799B
Date Value
September 16, 2026 2.688B
September 15, 2026 2.730B
September 14, 2026 2.857B
September 11, 2026 2.828B
September 10, 2026 2.825B
September 09, 2026 2.931B
September 08, 2026 2.909B
September 04, 2026 2.827B
September 03, 2026 2.852B
September 02, 2026 2.947B
September 01, 2026 3.060B
August 31, 2026 3.117B
August 28, 2026 3.120B
August 27, 2026 3.178B
August 26, 2026 3.274B
August 25, 2026 3.281B
August 24, 2026 3.032B
August 21, 2026 3.096B
August 20, 2026 3.132B
August 19, 2026 3.123B
August 18, 2026 3.027B
August 17, 2026 3.068B
August 14, 2026 3.113B
August 13, 2026 3.005B
August 12, 2026 2.871B

Enterprise Value Definition

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks
Start Trial
Kymera Therapeutics, Inc. 8.712B
Moderna, Inc. 94.23B
Abivax SA 7.003B
GRAIL, Inc. 5.152B
Arrowhead Pharmaceuticals, Inc. 8.079B